3D Systems Corp (3D Systems) provides comprehensive 3D printing solutions and digital manufacturing solutions. The company’ offers 3D printers and materials and software and related products. It also offers maintenance and training, advanced manufacturing and software services

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

3D Systems is actively engaged in R&D initiatives focused on 3D printing and regenerative medicine. The company conducts internally funded R&D, externally funded R&D, and partner- or co-funded R&D to develop new products, enhance its product portfolio, and improve its solutions. The company collaborates with research institutions, universities, customers, suppliers, and other partners to augment its R&D efforts. Additionally, 3D Systems is applying 3D printing technologies to develop transplantable organs and non-organ human applications, aiming to market these new products directly or with partners. The R&D units of 3D Systems include internally funded R&D, externally funded R&D, and partner- or co-funded R&D. These units are responsible for managing the company's R&D activities, including developing new products, enhancing the product portfolio, and expanding the capabilities of its solutions. At December 31, 2025, 3D Systems held 854 patents worldwide and had 258 pending patent applications. The company has entered into various licensing or cross-licensing arrangements with companies in the U.S. and other countries to utilize technologies in its products or allow others to use its technologies. The number of R&D centers, pipeline products, and major technology alliances is not specified in the input text. In FY2025, 3D Systems incurred an expenditure of US$65 million on R&D, which as a percentage of revenue, stood at 5.9%.